We are dedicated to pushing the boundaries of scientific progress, embracing innovation from any source. Our commitment is to recognize and bring forward the most promising advancements. By collaborating with the most brilliant minds in science and healthcare, we aim to address the challenges of treating complex diseases, both in the present and for generations to come.

Areas of interest:

We seek partners that have

• Differentiated assets in Brucella infections in animals;

• Opportunities to access the large and growing market in China; and

• Opportunities to establish or expand access in the U.S., Europe, and other markets

Partnering capabilities

At the core of our company’s inception is a dedication to groundbreaking scientific endeavors that directly enhance clinical outcomes—a commitment that endures. Leveraging our expansive resources and agility in expediting product development, we actively collaborate with partners to address a diverse range of use case complexities.